abstract: Predictors of Long-Term Outcome from Intraperitoneal Radioimmunotherapy for Ovarian Cancer. Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Saturday, January 14, 2012

abstract: Predictors of Long-Term Outcome from Intraperitoneal Radioimmunotherapy for Ovarian Cancer.



"A statistically significant improvement in progression-free survival (p≤0.05) was noted for less bulky disease and younger age. Administration of paclitaxel plus IFN, an immune response, and use of (90)Y showed a favorable nonsignificant trend. Dose escalation of radionuclide did not change risk of progression; thus, this therapy may have therapeutic efficacy at modest dose levels."

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.